Exclusive Summary

• Sildenafil's patents have long expired, leading to a mature global generic market where it maintains huge demand for erectile dysfunction (ED) treatment through competitive pricing and distribution channels.
• ED is highly prevalent worldwide, increasing with age, affecting over 300 million men globally, driving continuous market expansion.
• Sildenafil is listed on the WHO Essential Medicines List and recommended as a first-line treatment for ED, demonstrating strong clinical value and guideline endorsement.
• Chinese generics can stand out in the global market through high-quality production compliant with ICH standards, international registration experience, and competitive cost advantages.
• The product is suitable for DTC or offline channel distribution, exhibiting high market penetration and long-term stable demand with excellent commercial returns.